19-11061788-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_003072.5(SMARCA4):c.4916G>T(p.Arg1639Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1639H) has been classified as Likely benign.
Frequency
Consequence
NM_003072.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.5012G>T | p.Arg1671Leu | missense_variant | Exon 36 of 36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.4916G>T | p.Arg1639Leu | missense_variant | Exon 35 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.5012G>T | p.Arg1671Leu | missense_variant | Exon 36 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.4916G>T | p.Arg1639Leu | missense_variant | Exon 35 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.4922G>T | p.Arg1641Leu | missense_variant | Exon 35 of 35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.4826G>T | p.Arg1609Leu | missense_variant | Exon 35 of 35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.4826G>T | p.Arg1609Leu | missense_variant | Exon 34 of 34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.4826G>T | p.Arg1609Leu | missense_variant | Exon 34 of 34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.4823G>T | p.Arg1608Leu | missense_variant | Exon 35 of 35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.4337G>T | p.Arg1446Leu | missense_variant | Exon 32 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.3566G>T | p.Arg1189Leu | missense_variant | Exon 28 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.3548G>T | p.Arg1183Leu | missense_variant | Exon 27 of 27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.3410G>T | p.Arg1137Leu | missense_variant | Exon 27 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.3176G>T | p.Arg1059Leu | missense_variant | Exon 25 of 25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000538456.4 | c.980G>T | p.Arg327Leu | missense_variant | Exon 8 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 1671 of the SMARCA4 protein (p.Arg1671Leu). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 565470). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SMARCA4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R1671L variant (also known as c.5012G>T), located in coding exon 35 of the SMARCA4 gene, results from a G to T substitution at nucleotide position 5012. The arginine at codon 1671 is replaced by leucine, an amino acid with dissimilar properties. Missense and in-frame variants in SMARCA4 are known to cause neurodevelopmental disorders; however, such associations with rhabdoid tumor predisposition syndrome including small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Jelinic P et al. Nat Genet. 2014 May;46(5):424-6). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the supporting evidence, the association of this alteration with Coffin-Siris syndrome is unknown; however, the association of this alteration with rhabdoid tumor predisposition syndrome is unlikely. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at